
Keywords: Burkitt lymphoma (BL); Diffuse large B-cell lymphoma (DLBCL); Posttransplant lymphoproliferative disease (PTLD); Anaplastic large cell lymphoma (ALCL); Hodgkin lymphoma (HL); Langerhans cell histiocytosis (LCH); Juvenile xanthoganuloma (JXG); Rosai-Dorfma